Searched for
PHARMACEUTICAL PRODUCTION IN INDIA
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- India attracted $843 billion in FDI between 2014-15 and 2025-26: OfficialIndia has seen a significant rise in Foreign Direct Investment, attracting USD 843 billion between 2014-15 and 2025-26. Key government init...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- India-Oman trade pact to open huge export opportunities for labour-intensive sectors: ExpertsIndia and Oman's new trade pact unlocks significant export potential for sectors like textiles, gems, and marine products. This agreement a...
- India considers extending import tax exemption on petrochemicals to beyond June 30India will consider extending import tax exemptions on petrochemicals used for making plastics and pharmaceutical goods beyond June 30 to...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- Assam CM Himanta Biswa Sarma meets 'Team Europe' delegation to boost trade, investment linkagesAssam Chief Minister Himanta Biswa Sarma met the "Team Europe" EU delegation to boost trade and investment. The two-day visit focuses on se...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- India willing to open its market to high-quality, innovative pharma products, says commerce ministerIndia is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...
- Indian industry invests CAD 11 billion in Canada, generates over 33,000 jobs: reportIndian companies have invested close to CAD 11 billion in Canada. These investments span various sectors, creating over 33,000 jobs. Indian...
- Packaging firms remain upbeat on FY27 growth despite raw material volatility amid West Asia crisisDespite these disruptions, companies like EPL Ltd, Uflex, and TCPL Packaging remain optimistic about FY27 growth, driven by strong domestic...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...
- India can increase seafood exports to $30 billion in five years: Piyush GoyalIndia targets $30 billion in seafood exports within five years. This ambitious goal involves increasing production and quality. The nation ...
- Govt sets up six sector groups to fast-track ‘Make in India 2.0’ pushIn a bold move towards self-sufficiency, India is ramping up its domestic manufacturing initiatives! Six government-led teams are tasked wi...
- Govt sets up 6 sector-specific groups to identify products to boost manufacturing, cut importsIndia is boosting domestic manufacturing. Six expert groups will identify 100 products to reduce import dependence. This initiative aims to...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
Load More
